New Developments in Oncology: Addressing Novel Therapies in Oncology and Hematology
Now in its 22nd year, New Developments in Oncology has offered a comprehensive view of advancements in treatments, techniques, and technologies for treating and managing cancer and blood diseases, as well as related symptoms. With a focus on the impact of research on health care delivery and outcomes, experts from across the country will engage in discussion of the state of the science and management of patients with breast cancer, thoracic malignancies, melanoma, lymphoma and prostate cancer. Cytokine Storm in Cancer therapy and COVID-19 as well as Castleman Disease will also be discussed. Through a collaborative, concerted effort between expert doctors and nurses, the Duke Cancer Network and Virginia Oncology Associates are excited to emphasize interprofessional approaches to cancer care, specifically in the management of patients with breast, lung, skin, and prostate cancer.
Discuss emerging research in the management of cancer.
Review current evidence-based best practices in the management of cancer.
Examine the elements of the treatment journey the cancer patient finds the most meaningful.
Highlight new concepts and latest developments in the management of breast cancer, thoracic malignancies, melanoma, lymphoma and prostate cancer.
Discuss cytokine storm in cancer
Discuss Castleman’s disease
- 5.75 ACPE - Pharmacist
- 5.75 AMA PRA Category 1 Credit(s)™
- 5.75 ANCC
- 5.75 JA Credit - AH
- 5.75 Approved for AMA PRA Category 1 Credit(s)™